secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2024-05-22T23:59:59+00:00
Accession:  0001005286-24-000071
Event type: leadership
Sentiment:  neutral
Materiality: 0.85
Item codes: 3.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore CEO James Hall resigns; Paul Josephs appointed CEO and director effective May 20
--------------------------------------------------------------------------------

- James G. Hall resigned as director, President and CEO effective May 19, 2024.
- Paul Josephs appointed President, CEO and director effective May 20, 2024.
- Josephs previously CEO of Woodstock Sterile Solutions (CDMO) from April 2021 to May 2024.
- Granted 525,000 RSUs (25k vested immediately, 100k/year over 5 years) and up to 1.5M PSUs with performance price targets from $7.50 to $35.00 per share.
- Josephs enters Tier 1 Change in Control Severance Plan benefits.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000071/0001005286-24-000071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000071/lndc-20240519.htm
  HTML page:      https://secwatch.observer/filing/0001005286-24-000071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer